These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 21064187)

  • 1. Validation of reference tissue model of PET ligand [¹¹C]+3-MPB for the muscarinic cholinergic receptor in the living brain of conscious monkey.
    Yamamoto S; Ohba H; Nishiyama S; Takahashi K; Tsukada H
    Synapse; 2011 Jun; 65(6):548-51. PubMed ID: 21064187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of novel PET ligands (+)N-[11C]methyl-3-piperidyl benzilate ([11C](+)3-MPB) and its stereoisomer [11C](-)3-MPB for muscarinic cholinergic receptors in the conscious monkey brain: a PET study in comparison with.
    Tsukada H; Takahashi K; Miura S; Nishiyama S; Kakiuchi T; Ohba H; Sato K; Hatazawa J; Okudera T
    Synapse; 2001 Feb; 39(2):182-92. PubMed ID: 11180506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of PET ligands (+)N-[(11)C]ethyl-3-piperidyl benzilate and (+)N-[(11)C]propyl-3-piperidyl benzilate for muscarinic cholinergic receptors: a PET study with microdialysis in comparison with (+)N-[(11)C]methyl-3-piperidyl benzilate in the conscious monkey brain.
    Nishiyama S; Tsukada H; Sato K; Kakiuchi T; Ohba H; Harada N; Takahashi K
    Synapse; 2001 Jun; 40(3):159-69. PubMed ID: 11304753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age differences in muscarinic cholinergic receptors assayed with (+)N-[(11)C]methyl-3-piperidyl benzilate in the brains of conscious monkeys.
    Tsukada H; Kakiuchi T; Nishiyama S; Ohba H; Sato K; Harada N; Takahashi K
    Synapse; 2001 Sep; 41(3):248-57. PubMed ID: 11418938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-related changes in muscarinic cholinergic receptors in the living brain: a PET study using N-[11C]methyl-4-piperidyl benzilate combined with cerebral blood flow measurement in conscious monkeys.
    Kakiuchi T; Ohba H; Nishiyama S; Sato K; Harada N; Nakanishi S; Tsukada H
    Brain Res; 2001 Oct; 916(1-2):22-31. PubMed ID: 11597587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscarinic receptor occupancy and cognitive impairment: a PET study with [11C](+)3-MPB and scopolamine in conscious monkeys.
    Yamamoto S; Nishiyama S; Kawamata M; Ohba H; Wakuda T; Takei N; Tsukada H; Domino EF
    Neuropsychopharmacology; 2011 Jun; 36(7):1455-65. PubMed ID: 21430646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of oxybutynin and imidafenacin on central muscarinic receptor occupancy and cognitive function: a monkey PET study with [(11)C](+)3-MPB.
    Yamamoto S; Maruyama S; Ito Y; Kawamata M; Nishiyama S; Ohba H; Yamada S; Tsukada H
    Neuroimage; 2011 Sep; 58(1):1-9. PubMed ID: 21712096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of [11C](+)3-MPB binding in brain of chronic fatigue syndrome with serum autoantibody against muscarinic cholinergic receptor.
    Yamamoto S; Ouchi Y; Nakatsuka D; Tahara T; Mizuno K; Tajima S; Onoe H; Yoshikawa E; Tsukada H; Iwase M; Yamaguti K; Kuratsune H; Watanabe Y
    PLoS One; 2012; 7(12):e51515. PubMed ID: 23240035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and evaluation of muscarinic cholinergic receptor ligands N-[11C]ethyl-4-piperidyl benzilate and N-[11C]propyl-4-piperidyl benzilate: a PET study in comparison with N-[11C]methyl-4-piperidyl benzilate in the conscious monkey brain.
    Nishiyama S; Sato K; Harada N; Kakiuchi T; Tsukada H
    Nucl Med Biol; 2000 Nov; 27(8):733-40. PubMed ID: 11150704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding kinetics of 11C-N-methyl piperidyl benzilate (11C-NMPB) in a rhesus monkey brain using the cerebellum as a reference region.
    Itoh T; Tanaka M; Kobayashi K; Suzuki K; Inoue O
    Ann Nucl Med; 2005 Sep; 19(6):499-505. PubMed ID: 16248387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging of the striatal and extrastriatal dopamine transporter with (18)F-LBT-999: quantification, biodistribution, and radiation dosimetry in nonhuman primates.
    Varrone A; Stepanov V; Nakao R; Tóth M; Gulyás B; Emond P; Deloye JB; Vercouillie J; Stabin MG; Jonsson C; Guilloteau D; Halldin C
    J Nucl Med; 2011 Aug; 52(8):1313-21. PubMed ID: 21764797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of
    Nabulsi NB; Holden D; Zheng MQ; Bois F; Lin SF; Najafzadeh S; Gao H; Ropchan J; Lara-Jaime T; Labaree D; Shirali A; Slieker L; Jesudason C; Barth V; Navarro A; Kant N; Carson RE; Huang Y
    J Nucl Med; 2019 Aug; 60(8):1147-1153. PubMed ID: 30733324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of PET studies with the very high-affinity dopamine D2/D3 receptor ligand [11C]FLB 457: re-evaluation of the validity of using a cerebellar reference region.
    Asselin MC; Montgomery AJ; Grasby PM; Hume SP
    J Cereb Blood Flow Metab; 2007 Feb; 27(2):378-92. PubMed ID: 16736043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PET imaging of ischemic neuronal death in the hippocampus of living monkeys.
    Zhao L; Yamashima T; Wang XD; Tonchev AB; Yamashita J; Kakiuchi T; Nishiyama S; Kuhara S; Takahashi K; Tsukada H
    Hippocampus; 2002; 12(2):109-18. PubMed ID: 12000112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of adenosine A2A receptors in the human brain using [11C]TMSX and positron emission tomography.
    Naganawa M; Kimura Y; Mishina M; Manabe Y; Chihara K; Oda K; Ishii K; Ishiwata K
    Eur J Nucl Med Mol Imaging; 2007 May; 34(5):679-687. PubMed ID: 17171358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics modeling and occupancy studies of a novel C-11 PET tracer for VAChT in nonhuman primates.
    Jin H; Zhang X; Yue X; Liu H; Li J; Yang H; Flores H; Su Y; Parsons SM; Perlmutter JS; Tu Z
    Nucl Med Biol; 2016 Feb; 43(2):131-9. PubMed ID: 26872437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of [(11)C]Cimbi-36 as an agonist PET radioligand for the 5-HT(2A) and 5-HT(2C) receptors in the nonhuman primate brain.
    Finnema SJ; Stepanov V; Ettrup A; Nakao R; Amini N; Svedberg M; Lehmann C; Hansen M; Knudsen GM; Halldin C
    Neuroimage; 2014 Jan; 84():342-53. PubMed ID: 23994452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of serotonin 5-HT1A receptor binding using positron emission tomography and [carbonyl-(11)C]WAY-100635-considerations on the validity of cerebellum as a reference region.
    Hirvonen J; Kajander J; Allonen T; Oikonen V; Någren K; Hietala J
    J Cereb Blood Flow Metab; 2007 Jan; 27(1):185-95. PubMed ID: 16685258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative PET analyses of regional [11C]PE2I binding to the dopamine transporter--application to juvenile myoclonic epilepsy.
    Odano I; Varrone A; Savic I; Ciumas C; Karlsson P; Jucaite A; Halldin C; Farde L
    Neuroimage; 2012 Feb; 59(4):3582-93. PubMed ID: 22056530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noninvasive evaluation of brain muscarinic receptor occupancy of oxybutynin, darifenacin and imidafenacin in rats by positron emission tomography.
    Yoshida A; Maruyama S; Fukumoto D; Tsukada H; Ito Y; Yamada S
    Life Sci; 2010 Jul; 87(5-6):175-80. PubMed ID: 20598326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.